Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 599

2.

Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.

Cui F, Luo H, Wang F, Zheng H, Gong X, Chen Y, Wu Z, Miao N, Kane M, Hennessey K, Hadler SC, Hutin YJ, Liang X, Yang W.

Vaccine. 2013 Dec 27;31 Suppl 9:J36-42. doi: 10.1016/j.vaccine.2012.11.061.

PMID:
24331019
3.

Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: children of Chinese mothers are at increased risk of breakthrough infection.

Hahné S, van den Hoek A, Baayen D, van der Sande M, de Melker H, Boot H.

Vaccine. 2012 Feb 21;30(9):1715-20. doi: 10.1016/j.vaccine.2011.12.071.

PMID:
22210140
4.

Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.

Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L.

Vaccine. 2014 Oct 21;32(46):6091-7. doi: 10.1016/j.vaccine.2014.08.078.

PMID:
25240752
5.

Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Sep 28;61:768-71.

6.

Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial.

Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, Bhutia K, Gupta E, Mukhopadhyay CK, Dutta AK, Trivedi SS.

J Viral Hepat. 2013 Nov;20(11):801-10. doi: 10.1111/jvh.12102.

PMID:
24168259
7.

The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China.

Li F, Wang Q, Zhang L, Su H, Zhang J, Wang T, Huang D, Wu J, Yan Y, Fan D.

Vaccine. 2012 Nov 19;30(49):7118-22. doi: 10.1016/j.vaccine.2012.09.031.

PMID:
23022150
8.

An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net.

Fischer G, Wang S, Ahring S, Fowler K, Hainline S, Chinglong M, Jacques-Carroll L, Bell B, Williams I.

Pediatr Infect Dis J. 2009 Jul;28(7):593-7. doi: 10.1097/INF.0b013e318196bf5c.

PMID:
19455073
9.

Chronic HBV infection among pregnant women and their infants in Shenyang, China.

Ding Y, Sheng Q, Ma L, Dou X.

Virol J. 2013 Jan 7;10:17. doi: 10.1186/1743-422X-10-17.

10.

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.

Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX.

J Hepatol. 2011 Dec;55(6):1215-21. doi: 10.1016/j.jhep.2011.02.032.

PMID:
21703206
11.

Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.

Evans AA, Cohen C, Huang P, Qian L, London WT, Block JM, Chen G.

Vaccine. 2015 Jun 12;33(26):3010-5. doi: 10.1016/j.vaccine.2015.01.054.

12.

Mother-to-infant transmission of hepatitis B virus: a Chinese experience.

Shao ZJ, Zhang L, Xu JQ, Xu DZ, Men K, Zhang JX, Cui HC, Yan YP.

J Med Virol. 2011 May;83(5):791-5. doi: 10.1002/jmv.22043.

PMID:
21360547
13.

Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus.

Willis BC, Wortley P, Wang SA, Jacques-Carroll L, Zhang F.

Pediatrics. 2010 Apr;125(4):704-11. doi: 10.1542/peds.2009-1831.

PMID:
20211952
14.

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M.

J Viral Hepat. 2009 Feb;16(2):94-103. doi: 10.1111/j.1365-2893.2008.01056.x.

PMID:
19175878
15.

[Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].

Xia GL, Gong J, Wang JJ, Meng ZD, Jia ZY, Cao HL, Liu CB.

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 May;24(5):362-5. Chinese.

PMID:
12820927
16.

Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.

Zhang L, Ko S, Lv J, Ji F, Yan B, Xu F, Xu A.

Hum Vaccin Immunother. 2014;10(9):2755-60. doi: 10.4161/hv.29648.

17.

Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.

Doherty R, Garland S, Wright M, Bulotsky M, Liss C, Lakkis H, Nikas A, Straus W.

Pediatr Infect Dis J. 2009 Sep;28(9):777-81. doi: 10.1097/INF.0b013e3181a06fad.

PMID:
19636283
18.

Screening of pregnant women for hepatitis B virus surface antigen (HBsAg) and subsequent management, Qiandongnan prefecture, Guizhou, China, 2010.

Huang Y, Li L, Sun X, Lu M, Liu H, Tang G, Wang D, Hutin YJ.

Vaccine. 2013 Dec 27;31 Suppl 9:J62-5. doi: 10.1016/j.vaccine.2013.05.103.

PMID:
24331022
19.

Hepatitis B vaccination in children: the Taiwan experience.

Ni YH, Chen DS.

Pathol Biol (Paris). 2010 Aug;58(4):296-300. doi: 10.1016/j.patbio.2009.11.002.

PMID:
20116181
20.

[Vertical HBV transmission in Jerusalem in the vaccine era].

Michaiel R, Margalit RC, Shteyer E, Ashur Y, Safadi R.

Harefuah. 2012 Dec;151(12):671-4, 722, 721. Hebrew.

PMID:
23330257
Items per page

Supplemental Content

Support Center